Literature DB >> 31212601

Programmed Cell Death-1 Receptor (PD-1)-Mediated Regulation of Innate Lymphoid Cells.

Grace Mallett1, Arian Laurence2, Shoba Amarnath3.   

Abstract

Programmed cell death-1 (PD-1) is a cell surface receptor that dampens adaptive immune responses. PD-1 is activated by the engagement of its ligands PDL-1 or PDL-2. This results in the inhibition of T cell proliferation, differentiation, cytokine secretion, and cytolytic function. Although a great deal is known about PD-1 mediated regulation of CD4+ and CD8+ T cells, its expression and function in innate lymphoid cells (ILCs) are yet to be fully deciphered. This review summarizes the role of PD-1 in (1) modulating ILC development, (2) ILC function, and (3) PD-1 signaling in ILC. Finally, we explore how PD-1 based immunotherapies may be beneficial in boosting ILC responses in cancer, infections, and other immune-related disorders.

Entities:  

Keywords:  ILC; PD-1; PDL-1

Year:  2019        PMID: 31212601      PMCID: PMC6601034          DOI: 10.3390/ijms20112836

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  9 in total

Review 1.  Ambiguous roles and potential therapeutic strategies of innate lymphoid cells in different types of tumor.

Authors:  Shijie Wang; Pin Wu; Yongyuan Chen; Ying Chai
Journal:  Oncol Lett       Date:  2020-06-16       Impact factor: 2.967

Review 2.  The Diverse Function of PD-1/PD-L Pathway Beyond Cancer.

Authors:  Weiting Qin; Lipeng Hu; Xueli Zhang; Shuheng Jiang; Jun Li; Zhigang Zhang; Xu Wang
Journal:  Front Immunol       Date:  2019-10-04       Impact factor: 7.561

3.  Loading of Primary Human T Lymphocytes with Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles Does Not Impair Their Activation after Polyclonal Stimulation.

Authors:  Marina Mühlberger; Harald Unterweger; Julia Band; Christian Lehmann; Lukas Heger; Diana Dudziak; Christoph Alexiou; Geoffrey Lee; Christina Janko
Journal:  Cells       Date:  2020-02-01       Impact factor: 6.600

Review 4.  Microenvironment Remodeling and Subsequent Clinical Implications in Diffuse Large B-Cell Histologic Variant of Richter Syndrome.

Authors:  Hélène Augé; Anne-Béatrice Notarantonio; Romain Morizot; Anne Quinquenel; Luc-Matthieu Fornecker; Sébastien Hergalant; Pierre Feugier; Julien Broséus
Journal:  Front Immunol       Date:  2020-12-14       Impact factor: 7.561

5.  T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression.

Authors:  Francisco Javier Gil-Etayo; Patricia Suàrez-Fernández; Oscar Cabrera-Marante; Daniel Arroyo; Sara Garcinuño; Laura Naranjo; Daniel E Pleguezuelo; Luis M Allende; Esther Mancebo; Antonio Lalueza; Raquel Díaz-Simón; Estela Paz-Artal; Antonio Serrano
Journal:  Front Cell Infect Microbiol       Date:  2021-02-26       Impact factor: 5.293

Review 6.  Role of PD-L1 in Gut Mucosa Tolerance and Chronic Inflammation.

Authors:  Marina Chulkina; Ellen J Beswick; Irina V Pinchuk
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

Review 7.  Differential Role of PD-1 Expressed by Various Immune and Tumor Cells in the Tumor Immune Microenvironment: Expression, Function, Therapeutic Efficacy, and Resistance to Cancer Immunotherapy.

Authors:  Myeong Joon Kim; Sang-Jun Ha
Journal:  Front Cell Dev Biol       Date:  2021-11-22

Review 8.  Emerging Trends in Immunotherapy for Cancer.

Authors:  Alok K Mishra; Amjad Ali; Shubham Dutta; Shahid Banday; Sunil K Malonia
Journal:  Diseases       Date:  2022-09-06

Review 9.  PD-1/PD-L1 in Cancer: Pathophysiological, Diagnostic and Therapeutic Aspects.

Authors:  Enrico Munari; Francesca R Mariotti; Linda Quatrini; Pietro Bertoglio; Nicola Tumino; Paola Vacca; Albino Eccher; Francesco Ciompi; Matteo Brunelli; Guido Martignoni; Giuseppe Bogina; Lorenzo Moretta
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.